Bellevue Group AG Trims Stock Position in Privia Health Group, Inc. $PRVA

Bellevue Group AG lessened its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 9.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 630,697 shares of the company’s stock after selling 66,611 shares during the period. Bellevue Group AG owned approximately 0.51% of Privia Health Group worth $14,506,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Russell Investments Group Ltd. grew its position in shares of Privia Health Group by 2,852.2% during the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock valued at $60,000 after purchasing an additional 2,567 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its position in shares of Privia Health Group by 2,115.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock worth $75,000 after buying an additional 3,173 shares in the last quarter. CWM LLC boosted its stake in Privia Health Group by 89.4% during the second quarter. CWM LLC now owns 3,416 shares of the company’s stock valued at $79,000 after buying an additional 1,612 shares during the period. Canada Pension Plan Investment Board boosted its stake in Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company’s stock valued at $85,000 after buying an additional 1,200 shares during the period. Finally, Raymond James Financial Inc. purchased a new position in Privia Health Group during the second quarter worth about $113,000. 94.48% of the stock is owned by institutional investors.

Privia Health Group Stock Up 0.4%

Shares of NASDAQ:PRVA opened at $24.91 on Friday. The stock has a market cap of $3.06 billion, a PE ratio of 191.63, a PEG ratio of 4.28 and a beta of 0.83. The company’s fifty day moving average is $24.44 and its 200 day moving average is $22.79. Privia Health Group, Inc. has a 52 week low of $18.77 and a 52 week high of $26.51.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. The business had revenue of $213.61 million during the quarter. Sell-side analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current year.

Analyst Ratings Changes

Several analysts have weighed in on PRVA shares. Evercore ISI raised their price target on Privia Health Group from $28.00 to $30.00 and gave the company an “outperform” rating in a report on Friday, November 7th. Stephens reaffirmed an “overweight” rating and issued a $32.00 target price on shares of Privia Health Group in a research note on Thursday, December 4th. Barclays boosted their price target on shares of Privia Health Group from $22.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Monday, November 10th. Citizens Jmp increased their price target on shares of Privia Health Group from $30.00 to $31.00 and gave the stock a “market outperform” rating in a report on Friday, November 7th. Finally, Zacks Research raised shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 19th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $30.00.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.